Spring til hovednavigation Spring til søgning Spring til hovedindhold

Lifestyle intervention for weight management and prevention of type 2 diabetes and cardiovascular disease: Influence of age, sex, and metabolic statusThe PREVIEW study

Publikation: Ph.d.-afhandling

Abstract

The global prevalence of obesity is increasing. Obesity is related to an increased risk of type 2 diabetes and cardiovascular diseases (CVD). Lifestyle-based weight management programmes have been shown to aid weight loss and improve risk factors of type 2 diabetes and CVD in several large-scale, long-term intervention studies. Clinical guidelines from the American Heart Association and American Diabetes Association therefore recommend weight loss for individuals with overweight or obesity to prevent type 2 diabetes and CVD. It is unclear whether the clinical guidelines would benefit specific populations or whether personalized interventions are needed. Several previous studies have investigated the associations of participants’ baseline characteristics (e.g. age, sex, prediabetes phenotype, and obesity phenotype) with the effect of lifestyle interventions. Evidence based on the long-term, large-scale interventions, however, is scarce.
This PhD thesis was based on the data from the PREVIEW (PREVention of diabetes through lifestyle interventions and population studies In Europe and around the World) study, a 3-year, large-scale, multinational randomized controlled trial. The overall objective of this PhD thesis was to examine whether age, sex, prediabetes phenotype, and obesity phenotype would influence the effect of a lowenergy diet followed by a 3-year lifestyle intervention on health outcomes: body weight, type 2 diabetes incidence, and cardiometabolic risk factors in a large and high-risk cohort.
In Paper I, the aim of the study was to examine age- and sex-specific effects of a low-energy diet followed by a long-term lifestyle intervention on body weight, type 2 diabetes incidence, and cardiometabolic risk factors. A total of 2223 participants (783 younger, 25−45 years; 319 middleaged, 46−54 years; and 1121 older adults, 55−70 years; and 1503 women and 720 men) with
overweight and prediabetes were included in the analysis. During the study, participants underwent 8-week rapid weight loss followed by a 148-week lifestyle-based weight-loss maintenance
intervention. We found that compared with younger adults, older adults benefited less from a lifestyle intervention in relation to body composition and cardiometabolic risk factors. Compared with men, women benefited less in relation to body composition. Compared with older adults, middle-aged adults had higher 3-year cumulative incidence of type 2 diabetes. There were no differences in type 2 diabetes incidence between other age groups.
In Paper II, the study aimed to determine whether the effect of a low-energy diet followed by 3-year lifestyle intervention on body weight, type 2 incidence, and cardiometabolic risk factors would differ 6
by prediabetes phenotype. In total, 1510 participants with prediabetes were stratified into metabolic phenotypes: isolated impaired fasting glucose (iIFG), isolated impaired glucose tolerance (iIGT), and both iIFG and IGT (IFG+IGT). They were also classified as having normal hemoglobin A1c (HbA1c, <39 mmol·mol-1) and having intermediate HbA1c (39–47 mmol·mol-1). During the study, participants underwent 8-week rapid weight loss followed by a 148-week lifestyle-based weight-loss maintenance intervention. We found that individuals with iIFG and IFG+IGT had similar improvements in cardiometabolic risk factors after the lifestyle intervention, despite greater sustained weight loss in those with IFG+IGT. There were no differences in 3-year type 2 diabetes incidence among
prediabetes phenotypes. Participants with prediabetic hyperglycemia and normal vs intermediate HbA1c had similar weight changes over 3 years. During weight maintenance, those with normal HbA1c levels had greater improvements in cardiometabolic risk factors compared with those with
intermediate HbA1c. Individuals with normal HbA1c had lower 3-year 2 diabetes incidence and greater improvements in cardiometabolic risk factors than those with intermediate HbA1c.
In Paper III, we compared body weight, type 2 diabetes incidence, and cardiometabolic risk factors during a 3-year lifestyle intervention between adults with baseline metabolically healthy (MHO) vs unhealthy overweight/obesity (MUO). Participants were classified into MHO and MUO, according to baseline characteristics, i.e. waist circumference, fasting triglycerides, high‐density lipoprotein cholesterol, blood pressure, and fasting plasma glucose. During the study, participants underwent 8week rapid weight loss followed by a 148-week lifestyle-based weight-loss maintenance intervention.
We found that compared with those with baseline MHO, individuals with baseline MUO benefited more from rapid weight loss in relation to cardiometabolic risk factors. Participants with MHO benefited more from lifestyle intervention than those with MUO. Individuals with MUO had lower 3-year type 2 diabetes incidence than those with MHO after a lifestyle intervention.
In conclusion, based on the data from the PREVIEW study, we found that in a large-scale,
multinational, high-risk cohort, the 3-year effect of a lifestyle intervention may differ by age, sex, and metabolic status. After the 3-year lifestyle intervention, older adults benefited less in relation to body composition and cardiometabolic risk factors than younger adults. Women benefited less in relation to body weight and composition than men (Paper I). Compared with those with intermediate HbA1c, individuals with normal HbA1c had lower incidence of type 2 diabetes and greater improvements in cardiometabolic risk factors after the lifestyle intervention. (Paper II). Individuals with MHO had lower incidence of type 2 diabetes and greater improvements in cardiometabolic risk factors than those with MUO after the lifestyle intervention. (Paper III).

Citationsformater